Chemotherapy Combined With Recombinant Human Endostatin (Endostar) Significantly Improves the Progression-Free Survival of Stage IV Soft Tissue Sarcomas

PURPOSE: Our previously study showed that recombinant human endostatin (Endostar) combined with chemotherapy had significant activity to increase the mPFS in patients with advanced sarcomas with tolerable side effects. However, the small cohort size and short follow-up time made it difficult to scre...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Zhichao, Zhang, Chao, Yang, Tielong, Liu, Haotian, Yang, Songwei, Li, Ting, Xing, Ruwei, Teng, Sheng, Yang, Yun, Zhao, Jun, Zhao, Gang, Bai, Xu, Zhu, Lei, Yang, Jilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761904/
https://www.ncbi.nlm.nih.gov/pubmed/35047396
http://dx.doi.org/10.3389/fonc.2021.778774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761904/
https://www.ncbi.nlm.nih.gov/pubmed/35047396
http://dx.doi.org/10.3389/fonc.2021.778774

Ejemplares similares